Literature DB >> 28657427

Expression of Metabolic Syndrome in Women with Severe Obesity.

James L Hopkins1, Paul N Hopkins1, Eliot A Brinton2, Ted D Adams1,3, Lance E Davidson1,4, M Nazeem Nanjee1, Steven C Hunt1,5.   

Abstract

BACKGROUND: The prevalence of metabolic syndrome (MetS) generally rises with increasing adiposity, but tends to plateau at the highest levels of body mass index (BMI) with some individuals, even with severe obesity, expressing few or no components of MetS. We examined factors associated with the expression of MetS in severely obese women participating in a large observational study.
METHODS: Anthropometrics, including Heath equation-adjusted bioimpedance-determined fat-free mass (FFM) and fat mass (FM), lipids and related laboratory measurements, resting energy expenditure (REE), and respiratory quotient (RQ), were studied in 949 women with severe obesity.
RESULTS: Even though the mean BMI was 45.7 kg/m2 and all participants met MetS criteria for increased waist circumference, 30% of subjects did not have MetS. Unadjusted FM (P = 0.0011), FFM (P < 0.0001), and REE (P < 0.0001) were greater in the women with MetS. Surprisingly, in multivariate logistic regression FFM was positively associated with MetS (P = 0.0002), while FM was not (P = 0.89). Moreover, FFM, not FM, was significantly associated with all five components of MetS except for triglyceride levels. REE and RQ were higher in those with MetS, and REE was strongly associated with multiple components of MetS.
CONCLUSIONS: In women with severe obesity, higher FFM and REE were paradoxically associated with increased rather than decreased risk of MetS, while FFM-adjusted FM was unrelated to MetS.

Entities:  

Keywords:  insulin; liver enzymes; metabolic syndrome; obesity

Mesh:

Substances:

Year:  2017        PMID: 28657427      PMCID: PMC5564055          DOI: 10.1089/met.2016.0116

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  49 in total

Review 1.  Adipose tissue remodeling and obesity.

Authors:  Kai Sun; Christine M Kusminski; Philipp E Scherer
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Accelerated purine nucleotide degradation by anaerobic but not by aerobic ergometer muscle exercise.

Authors:  H Yamanaka; Y Kawagoe; A Taniguchi; N Kaneko; S Kimata; S Hosoda; N Kamatani; S Kashiwazaki
Journal:  Metabolism       Date:  1992-04       Impact factor: 8.694

3.  Adiposopathy is "sick fat" a cardiovascular disease?

Authors:  Harold E Bays
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

4.  The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.

Authors:  Maryann Maximos; Fernando Bril; Paola Portillo Sanchez; Romina Lomonaco; Beverly Orsak; Diane Biernacki; Amitabh Suman; Michelle Weber; Kenneth Cusi
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

5.  Metabolic predictors of obesity: cross-sectional versus longitudinal data.

Authors:  E Ravussin; B A Swinburn
Journal:  Int J Obes Relat Metab Disord       Date:  1993-12

6.  Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.

Authors:  Martin Brochu; Marie-Eve Mathieu; Antony D Karelis; Eric Doucet; Marie-Eve Lavoie; Dominique Garrel; Rémi Rabasa-Lhoret
Journal:  Obesity (Silver Spring)       Date:  2008-02-28       Impact factor: 5.002

7.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

8.  Bioimpedance for severe obesity: comparing research methods for total body water and resting energy expenditure.

Authors:  Gladys W Strain; Jack Wang; Michel Gagner; Alfons Pomp; William B Inabnet; Steven B Heymsfield
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

9.  A low resting metabolic rate is associated with metabolic syndrome.

Authors:  Silvio Buscemi; Salvatore Verga; Gregorio Caimi; Giovanni Cerasola
Journal:  Clin Nutr       Date:  2007-10-23       Impact factor: 7.324

Review 10.  Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology.

Authors:  Richard J Johnson; Peter Stenvinkel; Sandra L Martin; Alkesh Jani; Laura Gabriela Sánchez-Lozada; James O Hill; Miguel A Lanaspa
Journal:  Obesity (Silver Spring)       Date:  2013-04       Impact factor: 5.002

View more
  4 in total

1.  Association of Basal Metabolic Rate and Nutrients Oxidation with Cardiometabolic Risk Factors and Insulin Sensitivity in Sedentary Middle-Aged Adults.

Authors:  Francisco J Amaro-Gahete; Lucas Jurado-Fasoli; Jonatan R Ruiz; Manuel J Castillo
Journal:  Nutrients       Date:  2020-04-23       Impact factor: 5.717

2.  Increased odds of having the metabolic syndrome with greater fat-free mass: counterintuitive results from the National Health and Nutrition Examination Survey database.

Authors:  Jean-Christophe Lagacé; Alexis Marcotte-Chenard; Jasmine Paquin; Dominic Tremblay; Martin Brochu; Isabelle J Dionne
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-11-25       Impact factor: 12.910

3.  Sex Differences in Obesity and Cognitive Function in Chinese Elderly Patients With Chronic Schizophrenia.

Authors:  Wei Li; Sun Lin; Ling Yue; Yuan Fang; Shifu Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-01       Impact factor: 6.055

4.  Association between skeletal muscle mass or percent body fat and metabolic syndrome development in Japanese women: A 7-year prospective study.

Authors:  Yosuke Yamada; Haruka Murakami; Ryoko Kawakami; Yuko Gando; Hinako Nanri; Takashi Nakagata; Daiki Watanabe; Tsukasa Yoshida; Yoichi Hatamoto; Eiichi Yoshimura; Kiyoshi Sanada; Nobuyuki Miyatake; Motohiko Miyachi
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.